CSIMarket
 


Lantheus Holdings Inc   (LNTH)
Other Ticker:  
 


Lantheus Holdings Inc 's Net Profit Margin by quarter

Trends, Rankings, Statistics



LNTH Net Profit Margin (Dec 31 2023)
IV. Quarter
(Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
Y / Y Revenue Change 34.56 % 33.29 % 43.79 % 44 % 103.12 %
Seq. Revenue Change 11.02 % -0.85 % 6.95 % 14.29 % 9.98 %
Revenue In Millions $354.11 $318.95 $321.70 $300.78 $263.17
Net Profit Margin 29.19 % 41.37 % 29.26 % -0.93 % -45.29 %
Net Profit Margin Total Ranking # 338 # 229 # 456 # #
Net Income In Millions $103.38 $131.96 $94.13 $-2.81 $-119.19
Y / Y Net Income Change - 115.5 % 118.61 % - -
Seq. Net Income Change -21.66 % 40.18 % - - -


Commenting fourth Quarter 2023 Net Profit Margin
Company's Net Profit Margin sequentially deteriorated to 29.19 % due to increase in total costs and taxes and despite Revenue increase of 11.02 % to $354 millions.
Company's Net Profit Margin in IV. Quarter, was above company average.

Observing fourth quarter 2023 results within In Vitro & In Vivo Diagnostic Substances industry Lantheus Holdings Inc has achieved highest Net Profit Margin. While Net Profit Margin overall ranking has deteriorated compare to previous quarter from 229 to 338.
Net Margin Formula
LNTH's Net Profit Margin fourth quarter 2023 Company Ranking
Within: No.
In Vitro & In Vivo Diagnostic Substances Industry # 1
Healthcare Sector # 33
Overall # 338

Net Profit Margin Statistics
High Average Low
119.55 % 18.21 % 3.68 %
(Dec 31 2017)  




Other Net Profit Margin Profitability Ratios
LNTH's Cumulative Net Profit Margin
In Vitro & In Vivo Diagnostic Substances Industry Net Profit Margin Trends and Statistics
Healthcare Sector Net Profit Margin Statistics
Net Profit Margin Profitability Trends for overall market
LNTH's Net Profit Margin Profitability versus In Vitro & In Vivo Diagnostic Substances Industry, Healthcare Sector and total Market
Highest Ranking Net Profit Margin
Lowest Ranking Net Profit Margin
Net Profit Margin Profit Margin for LNTH's Competitors
Net Profit Margin Profit Margin for Lantheus Holdings Inc 's Suppliers
Net Profit Margin Profit Margin for LNTH's Customers

You may also want to know
LNTH's Annual Growth Rates LNTH's Profitability Ratios LNTH's Asset Turnover Ratio LNTH's Dividend Growth
LNTH's Roe LNTH's Valuation Ratios LNTH's Financial Strength Ratios LNTH's Net Income Growth
LNTH's Roa LNTH's Inventory Turnover Ratio LNTH's Growth Rates LNTH's Dividend Comparisons


Companies with similar Net Profit Margin in the quarter ending Dec 31 2023, within In Vitro & In Vivo Diagnostic Substances Industry Net Profit MarginDec 31 2023 MRQ Net IncomeDec 31 2023 MRQ Revenue
Lantheus Holdings Inc   29.19 %$ 103.380 $ 354.108 
Idexx Laboratories Inc  21.59 %$ 194.521 $ 901.163 




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com